Netupitant - Palonosetron Market Expected to Reach $527,187 Million, by 2022, Globally - Allied Market Research
PORTLAND, Oregon and PUNE, India, January 19, 2017 /PRNewswire/ --
According to a new report published by Allied Market Research, titled, "Netupitant Palonosetron Market: Global Opportunity Analysis and Industry Forecast, 2014-2022", the global netupitant-palonosetron was valued at $257,162 million in 2015, and is expected to reach $527,187 million by 2022, growing at a CAGR of 10.8% from 2016 to 2022.
(Logo: http://photos.prnewswire.com/prnh/20140911/647229 )
Summary of the Netupitant-Palonosetron Market Report can be accessed on the website at: https://www.alliedmarketresearch.com/netupitant-palonosetron-FDC-market
Netupitant-palonosetron FDC market holds a substantial scope for growth globally. The market is in its growth stage; however, its contribution to the global market is expected to increase significantly within the next six years. High cost is a major limitation to for the growth of the market in developing regions. However, recent innovations, which embed high potential and longer duration of action within the CINV drugs reach a wider segment of audiences. Numerous players are stepping in the CINV market with innovative products. Emerging technology such as novel drugs discovery and innovation of antiemetic therapy are expected to increase the competition in the near future.
According to Hemali Narkhede, Manager, Healthcare Research at Allied Market Research "Netupitant-Palonosetron FDC market holds a substantial scope for growth globally. The market, which is in its growth stage, however, is anticipated to contribute significantly to the global market within the next six years."
KEY FINDINGS OF THE STUDY
- North America dominated the netupitant-palonosetron market, and is expected to grow at a CAGR of 9.9%.
- Asia-Pacific shows the highest growth rate, and is estimated to grow at a CAGR of 14.7%.
Key players profiled in this report include Acacia Pharma, Helsinn Holding S.A., Heron Therapeutics, Inc., and Eisai Pharmaceutical Pvt Ltd.
Summary of Similar Reports can be accessed at: https://www.alliedmarketresearch.com/life-sciences/medical-devices-market-report
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
Pankaj Kumar
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Direct: +1-503-894-6022
Toll Free: +1 (800) 792-5285 (U.S. & Canada)
Fax: +1 (855) 550-5975
E-mail: [email protected]
SOURCE Allied Market Research
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article